Results 131 to 140 of about 1,316 (161)

Fahr's Syndrome Secondary to Hypoparathyroidism Presenting With Neurological and Cardiac Manifestations. [PDF]

Cureus
Elliott I, Dalvi S, Leong K, Wong S.
europepmc   +1 more source

Healthcare utilization patterns and medication burden in post-COVID syndrome: a cross-sectional analysis reveals four phenotypes. [PDF]

Front Health Serv
Hamberger J, Kraus L, Meissner K, Hinterberger T, Loew T, Schoeffski O, Gündel H, Walter S, Jarczok MN, Weimer K.   +9 more
europepmc   +1 more source

Colecalciferol

Reactions Weekly, 2011
null &NA;
core   +11 more sources

Calcium citrate/colecalciferol/colecalciferol overdose

Reactions Weekly, 2017
exaly   +3 more sources

Colecalciferol

, 1990
Karl-Heinz Beyer
exaly   +3 more sources

Colecalciferol

Reactions Weekly, 2016
Hammer, P., Schulte, A.
core   +6 more sources

Colecalciferol

Reactions Weekly, 2017
core   +5 more sources

Colecalciferol

Reactions Weekly, 2018
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Alendronate/Colecalciferol

Treatments in Endocrinology, 2005
Alendronate/colecalciferol 70 mg/2800 IU, a once-weekly tablet containing the bisphosphonate alendronate and colecalciferol (the precursor of the biologically active form of vitamin D), has been approved for the treatment of osteoporosis in women and for increasing bone mass in men with osteoporosis.
Neil A, Reynolds, Monique P, Curran
openaire   +2 more sources

Colecalciferol

Reactions Weekly, 2010
null &NA;
openaire   +2 more sources